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1 |  INTRODUCTION
A 9‐year‐old gelding presented with a medial lower eyelid 
squamous cell carcinoma. The tumor was resected “en‐bloc” 
and the margins treated with cryotherapy under general anes-
thetic. Reconstruction of the lower eyelid was achieved using 
a rhomboid blepharoplasty. In 12 months’ follow‐up period, 
no recurrence of the tumor was noted.
Squamous cell carcinoma (SCC) is the most common 
tumor of the equine orbit and adnexa and the second most 
common tumor in the horse overall.1 The prevalence of oc-
ular SCC in horses is positively correlated with increased 
exposure to ultraviolet light.2 Lack of skin pigmentation 
also increases the risk of becoming affected.2 Draught 
horses, the Haflinger breed, and Appaloosa horses have 
been shown to be predisposed to SCC development.2-4 A 
mutation in the damage‐specific DNA‐binding protein 2 
(DDB2) has been identified which increases the risk of 
developing SCC of the limbus and nictitans membrane in 
horses, specifically in the Haflinger and Belgium breeds.5,6 
A gender predilection has also been proposed with cas-
trated males being overrepresented,2,7,8 although this is 
not supported by other studies. This epithelial neoplasm 
in horses has been described originating from the cornea, 
limbus, conjunctiva, nictitans membrane, and eyelid.3,7-10 
Assessing the numbers from all these studies together 
shows that the most common site appears to be the nicti-
tans membrane (39%) and the second most common site 
the eyelids (29%).3,7-10
Ocular SCCs are typically highly locally invasive but 
the reported metastatic rate is low.8 Eyelid SCC has been 
shown to carry a poorer prognosis compared to other loca-
tions.10 The disease is usually unilateral, although bilateral 
squamous cell carcinomas have been described.8,11 The 
mainstay of treatment of eyelid SCC is surgical excision.12 
Recurrence after surgical excision is likely, particularly if 
clear surgical margins cannot be achieved.13 The recurrence 
rate reported varies and adjuvant therapy, such as cryother-
apy, radiofrequency hyperthermia, radiotherapy, topical and 
intralesional chemotherapy with cisplatin or 5‐fluorouracil, 
bacille Calmette‐Guerin (BCG) cell wall extract, and carbon 
dioxide laser ablation is often considered to avoid further 
recurrences.1,12
When eyelid surgery is considered, it is important to pre-
serve enough of the healthy tissue to maintain normal eyelid 
function.1 Blepharoplasties in horses are rarely reported in 
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the literature due to the challenges of sliding or moving the 
poorly mobile tissue around the horse eye1,14; subsequently, 
enucleation or exenteration may be required at the expense 
of a visual eye.15 The rhomboid blepharoplasty has been 
described for reconstruction of the medial canthus in the 
human16 and was described in one horse for reconstruction of 
the lateral canthus.17 This case report describes the treatment 
of a lower eyelid SCC in a horse with a rhomboid blepha-
roplasty procedure and cryotherapy with no recurrence in a 
12‐month follow‐up.
2 |  CASE REPORT
Ethical approval for this study was granted by the Royal 
Veterinary College’s Social Sciences Research Ethical 
Review Board (URN SR2017‐1088).
A 9‐year‐old Irish Draught gray gelding was referred 
to the Ophthalmology Department at the Royal Veterinary 
College (RVC) for the evaluation and treatment of an ocular 
SCC on the lower right eyelid in April 2017. The tumor had 
been diagnosed previously by histopathological examination 
of a biopsy from a 6x4mm mass taken by the referring veter-
inary surgeon.
2.1 | Initial ophthalmic examination
The horse presented to the RVC 18 days after the initial bi-
opsy was taken. The patient was bright, alert, and responsive. 
He was in good body condition and appeared to be in good 
overall health. Physical examination was unremarkable ex-
cept for mild enlargement of the left submandibular lymph 
node. The right submandibular lymph node was unremark-
able on palpation.
The patient was visual, with intact positive menace re-
sponses, dazzle and pupillary light reflexes in both eyes. A 
10 × 12 mm large, pigmented, raised, firm mass with an ul-
cerated hemorrhagic surface was present on the lower eyelid 
approximately 10 mm from the medial canthus (Figure 1). 
This mass was bulging from the medial lower eyelid mar-
gin and extending 5 mm into the conjunctival side of the 
eyelid (Figure 2). The surrounding conjunctiva and sclera 
were mildly hyperemic, and unilateral epiphora was noted. 
The surfaces of the left and right third eyelid were slightly 
irregular with a granular appearance. No abnormalities were 
detected on a complete examination of both globes using slit 
lamp biomicroscopy (Sl‐15; Kowa Ltd., Tokyo, Japan), and 
direct (Keeler Professional; Keeler Ltd., Windsor, UK) and 
indirect ophthalmoscopy (Keeler Vantage Plus; Keeler Ltd.). 
Intraocular pressure was estimated via rebound tonometry 
(TonoVet®; Icare Finland Oy, Helsinki, Finland) and was 
within normal limits.
2.2 | Clinical management
Surgical resection of the SCC and reconstruction of the eye-
lid under general anesthesia was planned for the following 
day at the RVC.
Surgery (“en‐bloc” excision, cryotherapy of the eyelid 
margins, and rhomboid blepharoplasty).
The patient was sedated using detomidine (Domidine; 
Dechra Veterinary Products, Shrewsbury, UK) 0.03 mg/
kg and morphine (Martindale Pharma, Buckinghamshire, 
Shrewsbury, UK) 0.1 mg/kg IV. General anesthesia was in-
duced with ketamine (Ketamidor®; Chanelle, Hungerford, 
UK) 2.2 mg/kg and midazolam (Hypnovel; Roche products 
Ltd, Welwyn Garden City, UK) 0.05 mg/kg IV followed by 
endotracheal intubation. General anesthesia was maintained 
using inhalational isoflurane (Isoflo; ABBOTT, Lake Bluff, 
IL, USA). The patient was positioned in left lateral recum-
bency. The lower eyelid of the right eye and medial canthus 
F I G U R E  1  Right eye at presentation with the eyelids in a 
physiologic position. Please note the lower eyelid mass affecting the 
medial part of the eyelid
F I G U R E  2  Right eye at presentation with the lower eyelid 
everted to show the extent of the mass at the conjunctival side of the 
eyelid
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were clipped. The clipped margins extended 10 cm ventral 
to the lower eyelid and 15 cm medial to the medial canthus. 
Sterile preparation of the surgical field was performed with 
1:10 Povidone Iodine: sterile 0.9% NaCl. The ocular surface 
was cleaned with 1:50 Povidone Iodine: sterile 0.9% NaCl. 
Full‐thickness skin incisions were made through the eyelid 
5 mm medial, lateral and ventral to the mass with a number 
15 blade (Swann Morton Ltd., Sheffield, UK) and Stevens 
tenotomy scissors, to achieve en‐bloc excision of the tumor 
(Figure 3B). These incisions were all of the same length so 
that a square of tissue was removed. Approximately, a third 
of the lower eyelid length was excised en‐block. The nasolac-
rimal apparatus was sacrificed and no attempt was made to 
preserve it. Hemostasis was achieved using handheld cautery 
(EYE CAUTERY; John Weiss & Son Ltd, Milton Keynes, 
UK). A handheld cryotherapy spray (CRYOSPRAY 59; 
Cuxon Gerrard & Co. Ltd., Oldbury, UK) was used to apply 
liquid nitrogen to the margins (Figure 3C). Two freeze‐thaw 
cycles were used of 10 seconds freezing then 60 seconds 
thawing. An incision was made extending ventromedially 
from the ventromedial aspect of the excision site. This inci-
sion was the same length as the previous incisions. A prox-
imal vertical incision was then made from the ventromedial 
edge of the last incision to create a rhomboid‐shaped skin 
graft (Figure 3D). Blunt dissection was used to undermine 
the rhomboid graft and the skin medial to the graft to mobi-
lize the tissue. The rhomboid graft was swung dorsally and 
laterally to fill the eyelid defect (Figure 3E). Extensive blunt 
dissection to undermine the subcutaneous tissue medially, 
ventrally and dorsally around the skin flap was required to 
achieve this degree of mobility. Subcutaneous sutures were 
placed to release tension using 4‐0 polydiaxanone (PDS®; 
Ethicon, Diegem, Belgium) in a simple interrupted pattern. 
A figure of eight suture with 6‐0 Polyglactin 910 (Vicryl®; 
Ethicon) was used to oppose the eyelid and the graft at the 
eyelid margin. Intradermal sutures (6‐0 Vicryl®; Ethicon) 
were used to close the skin, leaving a “Z” shaped pattern 
(Figure 3F). A temporary tarsorrhaphy was placed at the me-
dial canthus using two simple interrupted sutures to protect 
the graft from movement. Conjunctival biopsies were taken 
F I G U R E  3  Diagram showing the surgical procedure. A, The eyelid mass before surgery. Figure B, 5 mm margins for excision outlined. C, 
Full‐thickness excision of the eyelid mass. D, Rhomboid flap outlined. E, Undermining of the periocular skin (shaded yellow) to allow adequate 
movement of the flap. F, The rhomboid flap in position. It is then sutured in place
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from the upper eyelid, lower eyelid and nictitating membrane 
of both eyes. A fine needle aspirate of the left submandibu-
lar lymph node was taken and submitted for cytology. The 
excised tissue, along with the conjunctival biopsies and sub-
mandibular aspirate was submitted for histopathologic exam-
ination. An eye mask was placed to protect the surgery site 
from trauma during the postoperative period. Recovery from 
general anesthesia was uneventful.
2.3 | Laboratory results
Histopathology of the eyelid mass revealed an infiltrative 
densely cellular neoplasm of epithelial cells, consistent with 
a SCC (Figure 4). Tumor‐free margins were identified; how-
ever, neoplastic cell emboli were identified in lymphatic ves-
sels within the subconjunctival connective tissue deep to the 
mass. This suggested the possibility of future extension of 
the neoplasm to regional lymph nodes. Histopathology of the 
conjunctival biopsies revealed multifocal chronic lymphofol-
licular conjunctivitis, consistent with chronic inflammation. 
Cytology of the submandibular lymph node revealed a mildly 
reactive mixed lymphoid population. No evidence of meta-
static SCC was identified.
2.4 | Follow‐up
Postoperative oral medication consisted of oxytetracycline 
(Engemycin®; MSD Animal Health, Milton Keynes, UK) 
8 mg/kg IV q12 h and flunixin (Norbrook, Newry, UK) 
1.1 mg/kg IV q12 h intravenously for 6 days. The day after 
surgery the temporary tarsorrhaphy was removed due to ac-
cumulation of discharge. As a slight gap formation occurred 
on one of the ventral skin incisions away from the eyelids, 
staples were placed to achieve better apposition of the skin 
margins. Healing progressed well and the patient was bright 
and comfortable until discharge 6 days after surgery. The 
patient was discharged on doxycycline (Karidox®; Nimrod 
Veterinary Products Ltd., Moreton‐in‐Marsh, UK) 10 mg/
kg PO q12 h for ten days and suxibuzone (Danilon®; Elanco 
Animal Health, Basingstoke, UK) 2.2 g PO q12 h for 5 days. 
The patient was stall‐rested for 14 days postoperatively. The 
protective eye mask was kept in place during this period; the 
owner was instructed to remove the mask once daily to in-
spect the wound. The skin staples were removed 14 days after 
surgery. Re‐examination was performed 10 days, 1 month, 
and 12 months postoperatively (Figures 5 and 6). A cosmetic 
repair with normal lower eyelid motility was present. A nor-
mal palpebral reflex was present, and the eyelids covered 
the whole cornea during the blinking action. No evidence of 
recurrence was observed at the last examination 12 months 
postsurgery.
3 |  DISCUSSION
The case report describes the novel use of a rhomboid blepha-
roplasty in a horse following excision of a SCC and cryother-
apy of the wound margins. Blanchard and Keller previously 
described the use of a rhomboid flap for reconstruction of the 
lateral eyelids in a horse and a cat following removal of eyelid 
tumors, and of the medial and lateral canthus in two dogs.17 
F I G U R E  4  Hematoxylin and eosin showing a poorly 
differentiated squamous cell carcinoma. The tumor is effacing 
and ulcerating the conjunctiva and deeply infiltrates the subjacent 
fibroconnective tissue. There is destruction of Meibomian glands and 
secondary lymphoplasmacytic inflammation. Scale bar 1 mm. Inset: 
Neoplastic cells are often dyskeratotic and acantholytic. Note bizarre 
mitotic figures and cell cannibalism F I G U R E  5  Right eye 10 d postoperatively
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The rhomboid blepharoplasty has been described in the human 
for reconstruction of the medial canthus following surgical ex-
cision of basal cell carcinomas.16 To the authors’ knowledge, 
this is the first case where a medial rhomboid blepharoplasty 
was performed to reconstruct the lower eyelid in a horse.
Direct closure following excision of an eyelid mass using 
a simple wedge or four‐sided excision is only possible if less 
than one third of the eyelid margin is to be removed.18 Tumor‐
free margins of 2 cm have been recommended when attempt-
ing to achieve complete excision of squamous cell carcinomas 
in the horse, but are frequently impossible to achieve if the 
globe is to be spared.1,18 Studies have shown that surgical ex-
cision alone carries a high risk of recurrence.8,9,19 This is par-
ticularly true of eyelid squamous cell carcinomas, although 
neoplasms affecting the nictitating membrane carry a better 
prognosis following surgical excision.8,20 This is presumably 
because wider margins can be achieved more frequently.12 
Several blepharoplasty techniques have been described to fa-
cilitate closure of large eyelid defects in the equine. These 
include the sliding skin graft or "H"‐plasty,21 the tarsocon-
junctival advancement graft,14 the full‐thickness eyelid graft 
(Cutler‐Beard procedure),22 the rhomboid graft,17 and the 
sliding "Z" graft.14 The aim of these blepharoplasties is to re-
store a functional eyelid margin, with minimal complications 
on the ocular surface and an acceptable cosmetic appearance. 
In these techniques, a portion of the eyelid margin is replaced 
with haired skin, which may cause trichiasis. In other spe-
cies, different blepharoplasty techniques such as the Mustardé 
technique and lip to lid graft have been described to close 
large eyelid defects, which aim to maintain a mucocutaneous 
junction at the eyelid margin.23,24 Techniques such as these are 
limited in the equine, as the periorbital skin is tightly adherent 
to the underlying fascia and relatively immobile, while the 
thin eyelids are very delicate. This makes blepharoplasties in 
horses challenging, and the grafts prone to dehiscence and ne-
crosis.1,18 The advantages and disadvantages of each blepha-
roplasty technique must be considered for every case, in order 
to choose the one most suitable for the individual patient. The 
rhomboid blepharoplasty allows closure of a large eyelid de-
fect using haired skin. After a rhomboid graft is performed, 
the retraction force vectors are expected to be directed along-
side the palpebral fissure. This may be an advantage com-
pared to other blepharoplasties, for example, an H‐plasty, 
where these vectors are expected to develop perpendicularly 
to the palpebral fissure and potentially predispose to postop-
erative ectropion and lagophthalmus. Other techniques, such 
as lateral sliding grafts, rely on the transposition of normal 
eyelid tissue toward the defect while the haired skin covers an 
area of corneal surface away from the original defect. A slid-
ing graft of the lateral part of the lower eyelid toward the me-
dial area with a relaxation (burrows) triangle laterally could 
have been considered in this case. The surgeons prioritized 
not altering the lateral canthus and the normal lateral part of 
the lower eyelid. The advantage achieved with the rhomboid 
technique is that the cornea is shielded by the nictitans mem-
brane from trichiasis, thus minimizing the risk of postopera-
tive corneal irritation. Furthermore, if excision of a tumor is 
later shown to be incomplete on histopathology, sparing the 
lateral canthus would allow a sliding lateral blepharoplasty to 
be performed at a later date. One potential disadvantage of the 
rhomboid blepharoplasty was that the extensive mobilization 
of tissue at the medial canthus would require the sacrifice of 
the nasolacrimal apparatus. Because of the proximity of the 
tumor to the nasolacrimal puncta, attempting to preserve the 
nasolacrimal duct was considered likely to increase the risk of 
recurrence. In this case, loss of the nasolacrimal duct did not 
cause any clinical signs.
A combination of surgical excision or debulking with 
adjunctive therapy has been shown on numerous occasions 
to provide reduced recurrence rates compared to surgery 
alone.8,12,25-27 In the literature, various combination therapies 
have been described alongside surgery for treatment of eyelid 
SCC. These include photodynamic therapy,25 cryotherapy,8,9 
carbon dioxide laser,28 radiation therapy with strontium‐90, 
iridium‐192, cobalt‐60, radon‐222 or gold‐198,8,29-32 and 
chemotherapy with mitomycin C or cisplatin.8,11,33,34 There 
is currently insufficient evidence to compare the efficacy of 
these adjunctive therapies on eyelid SCCs.12
For this patient, it was elected to use cryotherapy of 
the margins following surgical excision of the SCC with 
5 mm margins. Cryotherapy can preserve normal structure 
and function of the tissue after healing.19 It is commonly 
used in combination with surgery for treatment of ocular 
SCCs, and has also been reported used alone without sur-
gery.9,35-37 Liquid nitrogen, nitrous oxide or carbon dioxide 
F I G U R E  6  Right eye 1 y postoperatively
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is used to reduce the temperature of the mass to between 
−20 and −40°C.12 Either a cryoprobe or a cryospray may 
be used. This treatment is used to target any malignant cells 
that may remain once the tumor has been excised, although 
there is potential for significant tissue damage to occur to 
neighboring tissue.12 The advantages of cryotherapy are 
that it causes reduced tissue scarring and relatively little 
postoperative pain compared to other therapies.12 It is also 
relatively low in cost.12,38
Success rates for cryotherapy of ocular and periocular 
SCC combined with surgery have been described in the liter-
ature. The prevalence of nonrecurrence ranges from 33.3%,9 
55%,36 to 100%.37 Nonrecurrence of periocular SCC was re-
ported in 66.7% of patients with cryotherapy alone.35 These 
studies were all limited by the small number of patients, and 
it is possible that the success rates were influenced by the po-
sition, and thus the behavior, of the SCC. However, it is clear 
that surgery combined with cryotherapy has potential to be a 
successful modality for treatment of this disease.
4 |  CONCLUSION
This case demonstrates that a rhomboid blepharoplasty can 
be used to achieve functional and cosmetic eyelid reconstruc-
tion at the medial canthus in the horse.
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